Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
DRUG: Chemotherapy
RFS, Recurrence free survival, the time interval from the date of surgery or the start of chemotherapy to clinically defined recurrence, disease progression, death from any cause or last follow-up|OS, Overall Survival, the time interval from the date of surgery or the start of chemotherapy to the date of death from any cause or last follow-up
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.